Sign up, start voting on articles and create your own news feeds! | Login | Create a free account

In encouraging sign, Ebola vaccine appears to provide long-lasting protection

This new paper stems from a follow-up. For this study, the Swiss researchers pooled data with two other groups that conducted Phase 1 trials of the vaccine in Africa — in Lambaréné, Gabon, and Kilifi, Kenya. In total, they had data from 197 people who ......

read more...

comments powered by Disqus

Published By: Kilifi - Monday, 16 April, 2018